ADITXT INC (ADTX)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$0.01+7.35%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · ADTX
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|---|
| Revenues | |||||||
| Revenues | 0.0 | 0.0 | 0.1 | 0.6 | 0.9 | 0.1 | — |
| Total Revenues | 0.0 | 0.0 | 0.1 | 0.6 | 0.9 | 0.1 | — |
| Cost of Revenues | 0.0 | 0.0 | 0.6 | 0.8 | 0.8 | 0.1 | — |
| Gross Profit | 0.0 | 0.0 | (0.5) | (0.1) | 0.2 | 0.0 | — |
| Operating Expenses & Income | |||||||
| Selling, General & Admin | — | — | — | — | 1.8 | 0.3 | 0.1 |
| R&D Expenses | 3.0 | 3.2 | 10.9 | 7.1 | 7.3 | 5.0 | 0.9 |
| Other Operating Expenses, Total | — | — | 8.1 | 6.2 | — | — | — |
| Operating Income | (18.3) | (19.6) | (27.9) | (26.1) | (25.5) | (41.9) | (8.9) |
| Earnings from Continuing Operations | |||||||
| Interest Expense | — | 0.7 | 4.2 | — | — | 0.0 | 0.0 |
| Interest & Investment Income | 0.2 | 0.2 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 |
| Net Interest Expenses | — | — | — | — | — | 0.0 | 0.0 |
| Other Non-Operating Income / Expenses | (34.7) | (23.2) | (7.2) | (6.3) | (2.2) | (4.4) | (0.3) |
| Asset Writedown | — | 0.4 | — | — | 0.5 | — | — |
| EBT, Incl. Unusual Items | (53.0) | (42.8) | (35.0) | (32.4) | (27.6) | (46.4) | (9.1) |
| Net Income | |||||||
| Minority Interest | (1.1) | (1.1) | (0.6) | (0.0) | — | — | — |
| Net Income | (53.3) | (43.1) | (40.4) | (32.7) | (27.6) | (46.4) | (9.1) |
| Per Share | |||||||
| Basic EPS | (2,643.94) | (1,153.83) | (3,062.51) | — | (597.12) | (121.18) | — |
| Diluted EPS | (2,643.94) | (1,153.83) | (3,062.51) | — | (595.60) | (121.18) | — |
| Revenue per Share | 0.71 | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.4 | — |
| Diluted Weighted Avg Shares | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.4 | — |
| Supplemental | |||||||
| EBIT | (18.3) | (19.6) | (27.9) | (26.1) | (25.5) | (41.9) | (8.9) |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.